Beginning antithrombotic therapy in an 84-year-old woman

Cardiology Review® OnlineSeptember 2007
Volume 24
Issue 9

An 84-year-old woman was admitted to the hospital because of fever, wheezing, and shortness of breath.

An 84-year-old woman was admitted to the hospital because of fever, wheezing, and shortness of breath. She had a history of hypertension, chronic atrial fibrillation, chronic obstructive pulmonary disease, and hypothyroidism that was attributed to the use of amiodarone (Cordarone, Pacerone). Her medications on admission were levothyroxine (Synthroid), short-acting beta agonists, ipratropium (Atrovent), enalapril (Vasotec), and aspirin.

Haemophilus influenzae

An electrocardiogram showed atrial fibrillation, with a ventricular rate of 108 beats/minute, right bundle-branch block, and ectopic ventricular beats. A chest x-ray showed mild cardiomegaly and peripheral infiltrates in the upper lobe of the left lung and the lingula. Laboratory tests showed the following values: hematocrit, 38%; white blood cell count, 17,300/mm3; platelet count, 140,000/mm3; sodium, 134 mmol/L; potassium, 4.2 mmol/L; and glucose, 147 mg/dL. An acute exacerbation of her symptoms because of pneumonia due to was diagnosed, and the patient was treated with ceftriaxone (Rocephin) 1 g twice a day plus levofloxacin (Levaquin) 500 mg/day.

According to the

, this patient would benefit from treatment with antithrombotic agents. Given her age and comorbid conditions, the benefits of long-term antithrombotic treatment were determined to outweigh the risks for this patient.

results of our study

Related Videos
Video 2 - "Lessons from EXPLORER-HCM: Unveiling CMIs' Potential in oHCM Treatment "
Video 1 - "Novel Cardio Myosin Inhibitors Targeting Obstructive Hypertrophic Cardiomyopathy's Root Cause "
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Heart Failure Treatment Outcomes and Contraindications
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
© 2024 MJH Life Sciences

All rights reserved.